|
|
|||
|
||||
OverviewNow viewed as its own scientific discipline, clinical trial methodology encompasses the methods required for the protection of participants in a clinical trial and the methods necessary to provide a valid inference about the objective of the trial. Drawing from the authors courses on the subject as well as the first author s more than 30 years working in the pharmaceutical industry, Clinical Trial Methodology emphasizes the importance of statistical thinking in clinical research and presents the methodology as a key component of clinical research. From ethical issues and sample size considerations to adaptive design procedures and statistical analysis, the book first covers the methodology that spans every clinical trial regardless of the area of application. Crucial to the generic drug industry, bioequivalence clinical trials are then discussed. The authors describe a parallel bioequivalence clinical trial of six formulations incorporating group sequential procedures that permit sample size re-estimation. The final chapters incorporate real-world case studies of clinical trials from the authors own experiences. These examples include a landmark Phase III clinical trial involving the treatment of duodenal ulcers and Phase III clinical trials that contributed to the first drug approved for the treatment of Alzheimer s disease. Aided by the U.S. FDA, the U.S. National Institutes of Health, the pharmaceutical industry, and academia, the area of clinical trial methodology has evolved over the last six decades into a scientific discipline. This guide explores the processes essential for developing and conducting a quality clinical trial protocol and providing quality data collection, biostatistical analyses, and a clinical study report, all while maintaining the highest standards of ethics and excellence. Full Product DetailsAuthor: Karl E Peace (Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, USA) , Ding-Geng Chen (University of Rochester, New York, USA)Publisher: CRC Press Imprint: CRC Press Volume: 35 ISBN: 9781322631721ISBN 10: 1322631727 Pages: 422 Publication Date: 01 January 2010 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: In stock We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsinformative discussions of mechanisms such as IND and NDA are unique strengths of this book, distinguishing it from the many other clinical trial texts available. Case studies are presented carefully The authors writing style is disciplined, careful, and informative. this is a helpful and informative book, a nice reference to have for most biostatisticians working on clinical trials. Mithat G nen, Journal of Biopharmaceutical Statistics, 21, 2011The book is an excellent overview predicated on the first author 's seasoned experiences in designing, analyzing, and communicating the results of clinical trials across a broad number of medical disciplines. A nice introductory feature is the history of drug law and regulation, which helps to frame the subsequent statistical discussion nicely. The real-world examples that dominate the last few chapters are fantastic. There is nothing like a series of examples from an experienced clinical trialist to whet the appetite of those involv Author InformationTab Content 6Author Website:Countries AvailableAll regions |